Author information from the last article
Avdeling for blodsykdommer
Oslo universitetssykehus
Forfatterbidrag: utforming, utarbeiding, revisjon og godkjenning av innsendte manusversjon.
Anders Eivind Myhre er overlege.
Articles by Anders Eivind Myhre
Vaccination of immunosuppressed patients
- Marton König,
- Trygve Holmøy,
- Gro Owren Nygaard,
- Jon Riise,
- Karsten Midtvedt,
- Guro Løvik Goll,
- Kristin Kaasen Jørgensen,
- Ludvig A. Munthe,
- Børre Fevang,
- Anders Eivind Myhre,
- Marius Trøseid
13.04.2026:
Chronically ill patients with a weak immune system are at increased risk of severe infections, often as a result of immunomodulatory therapy rather than the underlying disease. Many patients in this group exhibit reduced vaccine responses and require tailored vaccination regimens. Following the...
Allogeneic stem cell transplantation for patients with lymphoma 2011–21
- Hege Melby Frøen,
- Marianne Brodtkorb,
- Harald Holte,
- Arne Kolstad,
- Anders Eivind Myhre,
- Mats Remberger,
- Geir Erland Tjønnfjord,
- Tobias Gedde-Dahl
03.03.2025:
Allogeneic stem cell transplantation (ASCT) is potentially curative for patients with haematologic malignancies, lymphomas and certain non-malignant conditions. However, it carries a risk of severe complications and transplant-related mortality due to organ damage, infection and graft-versus-host...
Allogeneic stem cell transplantation in adults 2015–21
- Camilla Dao Vo,
- Anders Eivind Myhre,
- Ingerid Weum Abrahamsen,
- Mats Remberger,
- Jonas Mattsson,
- Yngvar Fløisand,
- Bjørn Christer Linder Grønvold,
- Geir Erland Tjønnfjord,
- Tor Henrik Anderson Tvedt,
- Tobias Gedde-Dahl
14.03.2023:
Allogeneic stem cell transplantation is the only curative treatment for a number of malignant haematological diseases and congenital or acquired immunodeficiencies. In allogeneic stem cell transplantation, the patient's own bone marrow is destroyed following pre-transplant treatment with high-dose...